Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by JrOGInvestoron Oct 09, 2024 1:25pm
161 Views
Post# 36259642

RE:RE:New info?

RE:RE:New info?The real value of this company will be unlocked soon after news breaks of a Letter of Intent with another pharma company or suitable suitor. How much it moves will depend on a few things like who the 'dance partner' is as that could also speed up getting into the US market. Even if it doesn't, they have the opportunity to reach globally as last counted there are roughly 25 countries that accepts Canada's Health Approvals, which avoids going through their own process as in the US with the FDA. 

When I say 'real value' it's just the tip of the iceberg - the patents held and the property they, 100 percent own, would suggest that this is already a 400 million dollar+ company, and that's not even taking into consideration the revenue stream from the carbon capture side of the house.

As someome put it earlier, once the news drops, you'll wake up one morning and it'll just be going.

Until then, keep the faith and GLTA!
<< Previous
Bullboard Posts
Next >>